|
1
|
Sagar SM, Yance D and Wong RK: Natural
health products that inhibit angiogenesis: A potential source for
investigational new agents to treat cancer-Part 1. Curr Oncol.
13:14–26. 2006.PubMed/NCBI
|
|
2
|
Wang S, Wu X, Tan M, Gong J, Tan W, Bian
B, Chen M and Wang Y: Fighting fire with fire: Poisonous Chinese
herbal medicine for cancer therapy. J Ethnopharmacol. 140:33–45.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nobili S, Lippi D, Witort E, Donnini M,
Bausi L, Mini E and Capaccioli S: Natural compounds for cancer
treatment and prevention. Pharmacol Res. 59:365–378. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bao X, Yuan H, Wang C, Liu J and Lan M:
Antitumor and immunomodulatory activities of a polysaccharide from
Artemisia argyi. Carbohydr Polym. 98:1236–1243. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamasuka T, Momoki Y and Sakai S:
Antitumor activity of polysaccharide fractions prepared from some
strains of Basidiomycetes. Gan. 59:443–445. 1968.PubMed/NCBI
|
|
6
|
Yin X, Ying J, Li L, Zhang H and Wang H: A
meta-analysis of lentinan injection combined with chemotherapy in
the treatment of nonsmall cell lung cancer. Indian J Cancer.
52:E29–E31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lim O, Jung MY, Hwang YK and Shin EC:
Present and future of allogeneic natural killer cell therapy. Front
Immunol. 6:2862015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Helfand SC, Soergel SA, Modiano JF, Hank
JA and Sondel PM: Induction of lymphokine-activated killer (LAK)
activity in canine lymphocytes with low dose human recombinant
interleukin-2 in vitro. Cancer Biother. 9:237–244. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Y, Meng FD, Tian X, Sui CG, Liu YP and
Jiang YH: Impact of IL-2 and IL-2R SNPs on proliferation and tumor-
killing activity of lymphokine-activated killer cells from healthy
chinese blood donors. Asian Pac J Cancer Prev. 15:7965–7970. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang WJ: Biochemistry technology of
polysaccharide compound (11-12th). Hangzhou: Zhejiang University
Press. 12–21. 1999.
|
|
11
|
Sounni NE and Noel A: Targeting the tumor
microenvironment for cancer therapy. Clin Chem. 59:85–93. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Trinchieri G: Cancer Immunity: Lessons
From Infectious Diseases. J Infect Dis. 212(Suppl 1): S67–S73.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo H, Callaway JB and Ting JP:
Inflammasomes: mechanism of action, role in disease, and
therapeutics. Nat Med. 21:677–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu R, Xiong S, Zhang L and Chu Y:
Enhancement of antitumor immunity by low-dose total body
irradiationis associated with selectively decreasing the proportion
and number of T regulatory cells. Cell Mol Immunol. 7:157–162.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
West EJ, Scott KJ, Jennings VA and Melcher
AA: Immune activation by combination human lymphokine-activated
killer and dendritic cell therapy. Br J Cancer. 105:787–795. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin CY, Chuang TF, Liao KW, Huang YJ, Pai
CC and Chu RM: Combined immunogene therapy of IL-6 and IL-15
enhances anti-tumor activity through augmented NK cytotoxicity.
Cancer Lett. 272:285–295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huyan T, Li Q, Yang H, Jin ML, Zhang MJ,
Ye LJ, Li J, Huang QS and Yin DC: Protective effect of
polysaccharides on simulated microgravity-induced functional
inhibition of human NK cells. Carbohydr Polym. 101:819–827. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng KC, Huang HC, Chen JH, Hsu JW, Cheng
HC, Ou CH, Yang WB, Chen ST, Wong CH and Juan HF: Ganoderma
lucidum polysaccharides in human monocytic leukemia cells: From
gene expression to network construction. BMC Genomics. 8:411–428.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ng ML and Yap AT: Inhibition of human
colon carcinoma development by lentinan from shiitake mushrooms
(Lentinus edodes). J Altern Complement Med. 8:581–589. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ren M, Ye L, Hao X, Ren Z, Ren S, Xu K and
Li J: Polysaccharides from Tricholoma matsutake and Lentinus edodes
enhance 5-fluorouracil-mediated H22 cell growth inhibition. J
Tradit Chin Med. 34:309–316. 2014. View Article : Google Scholar : PubMed/NCBI
|
